Skip to main content
. 2014 May 28;9:120. doi: 10.1186/1748-717X-9-120

Figure 2.

Figure 2

(A) Overall survival rate and (B) Disease progression-free survival rate from Cyberknife SBRT. The 1-yr. Overall survival rates and median survival time were 50% and 11 months, respectively. The 1 -yr. Disease progression-free survival rate and median disease-progression free survival rate were 31.8% and 6 months, respectively.